Literature DB >> 25847320

Expiratory positive airway pressure (EPAP) nasal device therapy: a welcome addition to obstructive sleep apnea syndrome therapy.

Sophia E Schiza1, Charalampos Mermigkis, Izolde Bouloukaki.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25847320     DOI： 10.1007/s11325-014-1069-7

Source DB:  PubMed          Journal:  Sleep Breath        ISSN： 1520-9512            Impact factor:   2.816


× No keyword cloud information.
  7 in total

1.  Predictors of response to a nasal expiratory resistor device and its potential mechanisms of action for treatment of obstructive sleep apnea.

Authors:  Amit V Patel; Dennis Hwang; Maria J Masdeu; Guo-Ming Chen; David M Rapoport; Indu Ayappa
Journal:  J Clin Sleep Med       Date:  2011-02-15       Impact factor: 4.062

2.  Complex sleep apnea associated with use of nasal expiratory positive airway (nEPAP) device.

Authors:  Amit Chopra; Piyush Das; Kannan Ramar; Bruce Staats; Erik K St Louis
Journal:  J Clin Sleep Med       Date:  2014-05-15       Impact factor: 4.062

3.  Pilot study of nasal expiratory positive airway pressure devices for the treatment of childhood obstructive sleep apnea syndrome.

Authors:  Suraiya A Kureshi; Paul R Gallagher; Joseph M McDonough; Mary Anne Cornaglia; Jill Maggs; John Samuel; Joel Traylor; Carole L Marcus
Journal:  J Clin Sleep Med       Date:  2014-06-15       Impact factor: 4.062

Review 4.  Adult obstructive sleep apnoea.

Authors:  Amy S Jordan; David G McSharry; Atul Malhotra
Journal:  Lancet       Date:  2013-08-02       Impact factor: 79.321

5.  Long-term compliance with continuous positive airway pressure in patients with obstructive sleep apnea.

Authors:  Norman Wolkove; Marc Baltzan; Hany Kamel; Richard Dabrusin; Mark Palayew
Journal:  Can Respir J       Date:  2008-10       Impact factor: 2.409

Review 6.  Adherence to continuous positive airway pressure therapy: the challenge to effective treatment.

Authors:  Terri E Weaver; Ronald R Grunstein
Journal:  Proc Am Thorac Soc       Date:  2008-02-15

7.  A novel nasal expiratory positive airway pressure (EPAP) device for the treatment of obstructive sleep apnea: a randomized controlled trial.

Authors:  Richard B Berry; Meir H Kryger; Clifford A Massie
Journal:  Sleep       Date:  2011-04-01       Impact factor: 5.849
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.